Office of Research & Development |
|
Project Number: | 1-I01CX002801-01A1 |
| Title: | Biomarker Directed trial of Temozolomide and PARP inhibition in relapsed SCLC |
| Principal Investigator: | Shadia Jalal |
| Location: | Indianapolis, IN |
| Congressional District Code: | 7 |
| Portfolio: | Precision Oncology Research |
| Project Period: | July 2025 - June 2030 |
| Total Award Amount: | $5,715,523 |
| Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |